Abnormal angiogenesis in diabetes mellitus

Alexandra Martin1, Michael R Komada, David C Sane

  • 1Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1045, USA.

Medicinal Research Reviews
|December 25, 2002
PubMed

Insights

Diabetes mellitus can cause abnormal blood vessel growth (angiogenesis), impacting organs like the eyes and kidneys. This review explores diabetes-related angiogenesis issues and potential treatments.

Area of Science:

  • Endocrinology
  • Vascular Biology
  • Diabetology

Background:

  • Diabetes mellitus is associated with widespread organ damage, often linked to hyperglycemia.
  • Abnormalities in angiogenesis (new blood vessel formation) are increasingly recognized as a key factor in diabetic complications.
  • Existing diabetes management primarily targets blood glucose control, potentially overlooking angiogenic factors.

Purpose of the Study:

  • To review the clinical manifestations of aberrant angiogenesis in diabetes mellitus.
  • To elucidate the molecular mechanisms underlying abnormal angiogenesis in diabetic patients.
  • To discuss potential therapeutic strategies for managing angiogenesis-related diabetic complications.

Main Methods:

  • This is a review article, synthesizing existing literature.
  • The review examines clinical observations and experimental findings related to angiogenesis in diabetes.
  • Molecular pathways and pathogenetic mechanisms are analyzed based on published research.

Main Results:

  • Diabetic patients exhibit vascular abnormalities in the retina, kidneys, and fetus.
  • Impaired wound healing, heightened transplant rejection risk, and poor coronary collateral formation are linked to aberrant angiogenesis.
  • Excessive and insufficient angiogenesis can paradoxically occur in different organs within the same diabetic individual.

Conclusions:

  • Aberrant angiogenesis is a significant contributor to the pathogenesis of numerous diabetic complications.
  • Understanding the molecular basis of abnormal angiogenesis is crucial for developing targeted therapies.
  • Future treatments may focus on modulating angiogenic processes to mitigate long-term diabetic sequelae.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...